Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SCIO Scios Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (1348)	5/21/2001 10:47:12 PM
From: Ian@SI	Respond to of 1477

Miljenko, Agreed that the sales are relatively small; that these are the first insider sales in the past 2 years other than Randall Kirk's sale in February. Even insiders have to live, send kids to school, buy cars/homes etc. I took my money, taxes and a nice profit off the table simply because I've had too many 10 baggers become 2 baggers or worse during the past year. Now SCIO is "house" money for me. And if the shorts or whomever is selling gets too carried away after the secondary is complete, I would have no qualms about loading up again. Each time I hear Brewer talk about Natrecor, the potential market seems to grow by several $100M. And I suspect that the P38 Kinase Inhibitor, if successful, will be a major out and out blockbuster. Even though I've been warned many times that such hopes are far too premature, I think they've got the toxicity concerns licked. My earlier post wasn't an encouragement for anyone else to sell; just pointing out another factor that might have been lurking in the shadows. Best wishes, Ian.